H.R. 5094: Protect Patients from Costly Care Act

This bill, known as the Protect Patients from Costly Care Act, aims to repeal certain changes related to Medicaid and Medicare that were previously enacted. Here are the key provisions of the bill:

Repeal of Changes to Medicaid Cost Sharing Requirements

The bill proposes to repeal specific alterations made to the Medicaid cost sharing requirements. Previously, these changes were part of a larger law, and their repeal means that the original rules regarding how much Medicaid beneficiaries must pay for services will remain in place. Additionally, any funds allocated under those changes will be rescinded, effectively reversing any financial adjustments associated with the new cost-sharing rules.

Repeal of Changes to Orphan Drug Exclusion under Drug Price Negotiation Program

The bill also seeks to repeal amendments that affected how orphan drugs—medications developed to treat rare diseases—are excluded from the Medicare Drug Price Negotiation Program. By reversing this change, the original exclusion protocols will again apply, meaning that these orphan drugs will not be included in the negotiated prices for Medicare, preserving the prior status of these medications in the program.

Impact on Existing Laws

This legislation is designed to reinstate certain provisions of the Social Security Act as they were before the changes were made, ensuring that the original legislative intent regarding Medicaid cost sharing and orphan drug pricing under Medicare will be upheld.

Relevant Companies

• None found